Recent studies have identified the NLRP3 inflammasome as a key nodal point in the pathogenesis of cardiomyopathies and heart dysfunction, which may create an opportunity to develop new therapeutic agents [16]. The gene discussed is NLRP3; the disease is cardiomyopathy.